Phibro Animal Health (PAHC) Change in Receivables (2013 - 2026)
Phibro Animal Health (PAHC) recorded quarterly Change in Receivables of $4.8 million in Q1 2026, up 304.71% quarter-over-quarter from -$2.3 million in Q4 2025, and up 37.64% on a YoY basis from $3.5 million in Q1 2025.
Phibro Animal Health (PAHC) Change in Receivables (2013 - 2026) Analysis & Trends
Phibro Animal Health's Change in Receivables history runs 14 years deep, the most recent figure standing at $4.8 million for Q1 2026.
- In Q1 2026, Change in Receivables rose 37.64% year-over-year to $4.8 million; the TTM figure through Mar 2026 stood at $17.0 million (down 58.43% YoY), while the FY2025 annual figure was $55.2 million, up 536.18% from the prior year.
- Change in Receivables was $4.8 million for Q1 2026 at Phibro Animal Health, up from -$2.3 million in the prior quarter.
- In the past five years, Change in Receivables ranged from a high of $35.0 million in Q4 2024 to a low of -$22.3 million in Q3 2022.
- Historically, Change in Receivables has averaged $4.4 million across 5 years, with a median of $4.8 million in 2026.
- The sharpest annual moves came in 2022 and 2024: Change in Receivables tumbled 411.02% in 2022, then surged 7819.86% in 2024.
- A 5-year view of Change in Receivables shows it stood at $7.5 million in 2022, then tumbled by 120.44% to -$1.5 million in 2023, then surged by 2379.41% to $35.0 million in 2024, then slumped by 106.67% to -$2.3 million in 2025, then surged by 304.71% to $4.8 million in 2026.
- The last three Change in Receivables figures came in at $4.8 million (Q1 2026), -$2.3 million (Q4 2025), and -$11.4 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | -78.00 Mn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | 106.00 Mn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | -38.20 Mn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | - |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | 81.40 Mn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | - |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | 23.22 Mn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | 116.25 Mn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | 2.23 Mn |
| 10 | Phibro Animal Health | 1.32 Bn | 1.24 Bn | 125.68 Mn | 4.78 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 4.78 Mn |
| Mar 31, 2026 | 4.78 Mn |
| Dec 31, 2025 | -2.33 Mn |
| Dec 31, 2025 | -2.33 Mn |
| Sep 30, 2025 | -11.37 Mn |
| Sep 30, 2025 | -11.37 Mn |
| Jun 30, 2025 | 25.96 Mn |
| Jun 30, 2025 | 25.96 Mn |
| Mar 31, 2025 | 3.47 Mn |
| Mar 31, 2025 | 3.47 Mn |
| Dec 31, 2024 | 34.99 Mn |
| Dec 31, 2024 | 34.99 Mn |
| Sep 30, 2024 | -9.21 Mn |
| Sep 30, 2024 | -9.21 Mn |
| Jun 30, 2024 | 11.72 Mn |
| Jun 30, 2024 | 11.72 Mn |
| Mar 31, 2024 | 11.27 Mn |
| Mar 31, 2024 | 11.27 Mn |
| Dec 31, 2023 | -1.54 Mn |
| Dec 31, 2023 | -1.54 Mn |